StableMarkets Profile Banner
Arman Oganisian Profile
Arman Oganisian

@StableMarkets

Followers
2K
Following
3K
Media
136
Statuses
2K

Statistician | Assistant professor at @BrownBiostats | Nonparametric Bayesian methods for causal inference. https://t.co/tdV1V2KpHg

Providence, RI
Joined March 2011
Don't wanna be here? Send us removal request.
@StableMarkets
Arman Oganisian
2 years
Excited to share that @PCORI has awarded funding for our proposed work developing Bayesian machine learning methods for causal inference! Thanks to Roee Gutman (co-PI) & others at @Brown_SPH https://t.co/dtOXdg0mvw @Brown_Epi @BrownUResearch @BrownMedicine @BrownUniversity
Tweet card summary image
pcori.org
2
5
81
@_samvelyan
Mikayel Samvelyan
15 days
I’m hiring a Student Researcher at @GoogleDeepMind. This research role centers on topics of open-ended self-improvement and discovery with LLM agents. 📍 Location: London 🗓️ Duration: 6 months, 100% 🚀 Start date: June or July 2026 Apply now using the links below👇
11
69
584
@StableMarkets
Arman Oganisian
2 months
Bayesian nonparametric models allow flexibility in regions w/ lots of data, while allowing priors about sensitivity parameters drive inference in regions w/o data (see bottom-right plot). Uncertainty about *all* unknowns flow into a single posterior for the causal quantity!
0
0
1
@StableMarkets
Arman Oganisian
2 months
Are some patients missing outcome info? Condition on data, make inferences about unknown {regression lines & missing values}. Think the missingness is not at-random? Condition on data, making inferences about unknown {regression lines, missing values, & sensitivity parameters}
1
0
1
@StableMarkets
Arman Oganisian
2 months
Why I find Bayesian nonparametric causal inference compelling in one figure. The key distinction is btwn (1) "known" vs (2) "unknown" quantities: Make inferences about (2) conditional on (1). Want cond. avg trt effects? Condition on data, make inferences about regression lines
2
4
26
@StableMarkets
Arman Oganisian
2 months
Congrats to @amalsargsyan & @GevTamamyan! When I first got involved, my mind went straight to the stats - but from black markets to the complexities of an out-of-pocket system, this was so much more. One step towards better cancer policy in Armenia🤞 https://t.co/wUOJByOG32
2
3
8
@StableMarkets
Arman Oganisian
3 months
We also discuss differences and similarities with methods for irregular visit processes that inverse-weight by the visit process intensity.
0
0
1
@StableMarkets
Arman Oganisian
3 months
... and how identifiability conditions may be read off a Single World Intervention Graph (SWIG) template for the implicit DTR.
1
0
1
@StableMarkets
Arman Oganisian
3 months
We discuss formalize connections between g-methods that use discrete-time versus continuous-time models adjustment models and the realtive pros/cons of each...
1
0
0
@StableMarkets
Arman Oganisian
3 months
Progress can be made by (1) casting waiting times between decisions as potential outcomes of previous treatments and (2) framing subsequent decisions as outputs of an implicit dynamic Treatment Rule (DTR).
1
0
0
@StableMarkets
Arman Oganisian
3 months
In causal inference problems w/ sequential treatments, long stretches of time may elapse between treatment decisions This paper, in press at Epidemiology, was really fun to write: it discusses biases that may arise & corresponding adjustment via g-methods https://t.co/RkzMhdxuP3
1
2
12
@StableMarkets
Arman Oganisian
3 months
I hope it’s a helpful resource for people adopting Bayesian methods in their causal work. Associated demo code here: https://t.co/0Doi3xhNsH
0
0
2
@StableMarkets
Arman Oganisian
3 months
I originally wrote this to share with trainees but was recently encouraged arXiv it. I touch on several Qs: Why does unit-level inference need stronger assumptions? When do/n’t we impute unit-level counterfactuals? How does this differ from g-computation? https://t.co/tFI4U6MvdD
1
4
23
@StableMarkets
Arman Oganisian
6 months
Streaming live now on YouTube: https://t.co/l38IO4wolz Andrew Gelman is talking about @StatModeling is talking about "Taking Our Models Seriously"
@StableMarkets
Arman Oganisian
6 months
StanBio Connect 2025: Advancing Biomedical Research with Stan This event is streaming live tomorrow and I’ll be speaking about some work on Bayesian causal inference with survival outcomes. https://t.co/4mVNFIRp91
0
1
11
@StableMarkets
Arman Oganisian
6 months
StanBio Connect 2025: Advancing Biomedical Research with Stan This event is streaming live tomorrow and I’ll be speaking about some work on Bayesian causal inference with survival outcomes. https://t.co/4mVNFIRp91
stanbio.org
Advancing Biomedical Research with Stan
0
3
10
@StableMarkets
Arman Oganisian
7 months
I’m teaching a 3-hour session on Bayesian causal inference at Penn Causal Inference Summer Institute, 5/27-5/30. Virtual attendance options are available. There are sessions on many other really cool topics as well -check out the agenda: https://t.co/bGods91YQ6
1
20
115
@Brown_SPH
Brown University School of Public Health
7 months
Congratulations to the students, staff & faculty honored Wednesday at the #BrownSPH 2025 Dean's Awards Ceremony!🏅 “You remind us that in moments of uncertainty,” Dean @ashishkjha said, “the mission of our school becomes not just relevant, but essential.” https://t.co/pZ52bmUtVo
0
2
10
@StableMarkets
Arman Oganisian
8 months
New paper here w/ Tony Linero on Bayesian causal inference: Independent priors on propensity score & outcome models often imply a strong prior on no *measured* confounding - a prior belief that 1) we rarely hold and 2) leads to bad frequentist performance https://t.co/GzN16Ze52w
@ObservStudies
Observational Studies
8 months
I'm pleased to announce the publication of our special issue featuring an opinion piece by Aronow, Robins, Saarinen, Sävje: “Nonparametric Identification Is Not Enough, but Randomized Controlled Trials Are" along with 6 commentaries:
0
8
35
@PharmEpi
Kaley Hayes, PharmD, PhD
8 months
Hot off the press from our @NIHAging osteoporosis R01: we created a multinational database of older adults in the US and Canada and found extreme shifts in which osteoporosis medications were used over the past decades. Notice anything interesting? https://t.co/er6V60knDg
1
4
8
@StableMarkets
Arman Oganisian
8 months
Slides for this talk are posted on my site! https://t.co/UDxlagT03B
@StableMarkets
Arman Oganisian
8 months
I’ll be talking about this paper on Bayesian causal inference w/ recurrent events @ #ENAR2025. Come check out our session! Session 50. It’s All Aabout the Estimand: Asking the Right Questions to Best Inform Health Policy Decisions March 24: 1:45-3:30pm; at Oakley, floor 4
0
12
41
@StableMarkets
Arman Oganisian
8 months
I’ll be talking about this paper on Bayesian causal inference w/ recurrent events @ #ENAR2025. Come check out our session! Session 50. It’s All Aabout the Estimand: Asking the Right Questions to Best Inform Health Policy Decisions March 24: 1:45-3:30pm; at Oakley, floor 4
@StableMarkets
Arman Oganisian
1 year
Check out our new paper developing Bayesian causal inference methods for recurrent event outcomes! We handle several complexities such as censoring, terminal events, and treatment timing misalignment. Best part: the Bayesian models are all implementable in Stan (@mcmc_stan).
1
5
32